Abstract

BackgroundHepatocellular carcinoma (HCC), usually known as hepatoma, is the third leading cause of cancer mortality globally. Early detection of HCC helps in its treatment and increases survival rates.ObjectiveThe aim of this study is to develop a deep learning model, using the trend and severity of each medical event from the electronic health record to accurately predict the patients who will be diagnosed with HCC in 1 year.MethodsPatients with HCC were screened out from the National Health Insurance Research Database of Taiwan between 1999 and 2013. To be included, the patients with HCC had to register as patients with cancer in the catastrophic illness file and had to be diagnosed as a patient with HCC in an inpatient admission. The control cases (non-HCC patients) were randomly sampled from the same database. We used age, gender, diagnosis code, drug code, and time information as the input variables of a convolution neural network model to predict those patients with HCC. We also inspected the highly weighted variables in the model and compared them to their odds ratio at HCC to understand how the predictive model worksResultsWe included 47,945 individuals, 9553 of whom were patients with HCC. The area under the receiver operating curve (AUROC) of the model for predicting HCC risk 1 year in advance was 0.94 (95% CI 0.937-0.943), with a sensitivity of 0.869 and a specificity 0.865. The AUROC for predicting HCC patients 7 days, 6 months, 1 year, 2 years, and 3 years early were 0.96, 0.94, 0.94, 0.91, and 0.91, respectively.ConclusionsThe findings of this study show that the convolutional neural network model has immense potential to predict the risk of HCC 1 year in advance with minimal features available in the electronic health records.

Highlights

  • Liver cancer is the sixth most cancer in incidence and the fourth leading cause of cancer-related mortality worldwide [1]

  • The overall area under the receiver operating curve (AUROC) of predicting Hepatocellular carcinoma (HCC) patients 1 year in advance was 0.94, with a sensitivity of 0.869 and a specificity of 0.865

  • The threshold for the output of the Convolutional neural network (CNN) model to classify the risk group was 0.11, which was chosen by the maximum sum value of the sensitivity and the specificity

Read more

Summary

Introduction

Liver cancer is the sixth most cancer in incidence and the fourth leading cause of cancer-related mortality worldwide [1]. The most common type of liver cancer is hepatocellular carcinoma (HCC), accounting for approximately 80% of all liver cancer [1]. The incidence and mortality rate of HCC are higher in Sub-Saharan Africa and Southeast Asia than in the United States [2]. HCC incidence has been increasing globally, including in the USA, and is expected to continue growing over the 20 years due to the higher number of patients with advanced hepatitis C virus and nonalcoholic steatohepatitis [3,4]. Hepatocellular carcinoma (HCC), usually known as hepatoma, is the third leading cause of cancer mortality globally. Detection of HCC helps in its treatment and increases survival rates

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call